Primary Contacts

Maria T. Currier
Partner
Miami

Maria T. Currier chairs the firm's National Healthcare and Life Sciences Team. With over 24 years of experience serving clients in the healthcare industry, her practice focuses on health...

View Full Profile

Jeffrey Mittleman
Partner
Boston

Jeffrey W. Mittleman is a partner in the Business Section of Holland & Knight and is a member of the firm's national Healthcare & Life Sciences Team and Compliance Services...

View Full Profile

Shannon Hartsfield Salimone
Partner
Tallahassee
Jacksonville

Shannon Hartsfield Salimone is the regulatory and litigation leader of the firm's Healthcare & Life Sciences Team. She practices in the area of health law, advising clients on state...

View Full Profile

Michael M. Gaba
Partner
Washington

Michael M. Gaba is a partner in the Washington, D.C. office of Holland & Knight where he is the federal policy leader of the firm’s national Healthcare & Life Sciences...

View Full Profile

  • Printer friendly
  • Email this page to a friend
  • Generate a PDF version of this page

Articles & White Papers
Healthcare & Life Sciences

Investigation into physician-owned distributors continues
 

Daily Journal

October 20, 2011
 
Maria T. Currier- Miami
Vince Farhat- Los Angeles

Healthcare & Life Sciences Chair Maria Currier and Partner Vince Farhat authored an article for the Daily Journal titled "Investigation into physician-owned distributors continues."

The article reports that the U.S. Senate Finance Committee launched a wide-ranging investigation into physician-owned distributors (PODs) that sell surgical implant devices to hospitals. Based on the interim responses received from The Health and Human Services Office of Inspector General (OGI) and the Centers for Medicare and Medicaid Services (CMS) that reviewed this rapidly growing segment of the healthcare industry, the legality of PODs remain in flux. In the article, Mr. Farhat and Ms. Currier advise hospitals that are considering purchasing implant from PODs, or physicians who are contemplating joining a POD, to carefully take into account the factors the OIG lists in its interim Senate response.

READ: Investigation into physician-owned distributors continues

Related Practices